2 not yet recruiting, 2 recruiting. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Not yet recruiting 2, Recruiting 2 |
Follow CHT101: new trials by email Literature Review of CHT101 trials Research Report on CHT101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate CHT101 Injection in Subjects With Relapsed/Refractory T-Cell and B-Cell Hematologic Malignancies CHT101 - Hematological Malignancies | Phase 1 | Not yet recruiting | Nanjing Miracle Biotechnology Co., Ltd. | 30 | 2026-09-01 | 2026-09-09 |
| A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies CHT101 - Peripheral T-cell Lymphoma, Cutaneous T-cell Lymphoma (CTCL) | Phase 1 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 24 | 2025-03-31 | 2025-04-06 |
| A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors CHT101 - Metastatic Tumor, Advanced Solid Tumor | Phase 1 | Not yet recruiting | Zhejiang University | 18 | 2024-04-22 | 2024-04-25 |
| A Clinical Study of CHT101 in CD70-Positive Advanced Solid Tumors CHT101 - Relapsed / Refractory Solid Tumor | Phase 1 | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 36 | 2024-04-19 | 2024-12-12 |
Carcinoma, Renal Cell (1) · Hematologic Neoplasms (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Cutaneous (1) · Lymphoma, T-Cell, Peripheral (1) · Nasopharyngeal Carcinoma (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Recurrence (1) · Squamous Cell Carcinoma of Head and Neck (1) · Uterine Cervical Neoplasms (1)
Tianjin Medical University Cancer Institute and Hospital (2) · Nanjing Miracle Biotechnology Co., Ltd. (1) · Zhejiang University (1)
China (3)